128 related articles for article (PubMed ID: 2570438)
1. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
[No Abstract] [Full Text] [Related]
2. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
[TBL] [Abstract][Full Text] [Related]
3. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
[TBL] [Abstract][Full Text] [Related]
4. [Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind study].
Fleischhacker WW; Barnas C; Stuppäck CH; Sperner-Unterweger B; Miller C; Hinterhuber H
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():10-3. PubMed ID: 1683332
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study.
Sarai K; Okada M
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680
[TBL] [Abstract][Full Text] [Related]
6. Clinical predictors of schizophrenic patient response to neuroleptics.
Korínková V
Act Nerv Super (Praha); 1989 Jun; 31(2):115-6. PubMed ID: 2572131
[No Abstract] [Full Text] [Related]
7. Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol.
Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
Int Clin Psychopharmacol; 1992; 7(1):23-7. PubMed ID: 1352521
[TBL] [Abstract][Full Text] [Related]
8. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
Cassano GB; Castrogiovanni P; Conti L; Bonollo L
Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
[No Abstract] [Full Text] [Related]
9. Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol.
Hwang TJ; Lin SK; Lin HN
J Formos Med Assoc; 2001 Dec; 100(12):811-6. PubMed ID: 11802520
[TBL] [Abstract][Full Text] [Related]
10. [Clinical trial of oxyprothepin decanoate (author's transl)].
Kabes J; Balon R; Hanzlícek L; Skovajsová M; Kozáková H
Cesk Psychiatr; 1980 Feb; 76(1):16-25. PubMed ID: 6103755
[No Abstract] [Full Text] [Related]
11. [Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study].
Filip V; Faltus F; Hanáková S; Janecková E; Raboch J; Dobiásová A; Karen P; Posmurová M
Cesk Psychiatr; 1985 Feb; 81(1):6-14. PubMed ID: 2858269
[No Abstract] [Full Text] [Related]
12. The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
Woggon B; Linden M; Beckmann H; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pflug B; Schied HW
Psychopharmacol Bull; 1986; 22(1):47-51. PubMed ID: 2873619
[No Abstract] [Full Text] [Related]
13. [Comparison of higher-dose haloperidol therapy with perazine standard therapy in acute schizophrenic patients].
Schmidt LG; Schüssler G; Kappes CV; Müller-Oerlinghausen B
Nervenarzt; 1982 Sep; 53(9):530-6. PubMed ID: 6127637
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
[No Abstract] [Full Text] [Related]
15. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
16. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
Wetzel H; von Bardeleben U; Holsboer F; Benkert O
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():23-9. PubMed ID: 1683336
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C
Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic effects of verapamil in schizophrenia.
Price WA
Hillside J Clin Psychiatry; 1987; 9(2):225-30. PubMed ID: 3323023
[TBL] [Abstract][Full Text] [Related]
19. Hyperhidrosis under combination of zotepine and haloperidol alleviated by aripiprazole.
Huang WL; Chang LR
Psychiatry Clin Neurosci; 2012 Apr; 66(3):245. PubMed ID: 22443252
[No Abstract] [Full Text] [Related]
20. Results of an open phase II study with zotepine--a new neuroleptic compound.
Fleischhacker WW; Unterweger B; Barnas C; Stuppäck C; Hinterhuber H
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):64-6. PubMed ID: 2883686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
